Inventor · disambiguated record
Qing Tang
Also filed as: TANG QING
44 granted patents·15 pending applications·839 citations·filing 2002–2025
98Inventor score
Top patents by PatentIndex Score
59 records- 0197US7345054B2Heterocyclic inhibitors of ERK2 and uses thereofVERTEX PHARMA·Filed 2005·Granted Mar 18, 2008·57 cites·9 claims
- 0296US7354939B2Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates theretoVERTEX PHARMA·Filed 2005·Granted Apr 8, 2008·52 cites·9 claims
- 0396US7304061B2Heterocyclic inhibitors of ERK2 and uses thereofVERTEX PHARMA·Filed 2003·Granted Dec 4, 2007·65 cites·22 claims
- 0496US6743791B2Heterocyclic inhibitors of ERK2 and uses thereofVERTEX PHARMA·Filed 2002·Granted Jun 1, 2004·123 cites·57 claims
- 0595US9359380B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Jun 7, 2016·19 cites·25 claims
- 0695US9340557B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted May 17, 2016·19 cites·26 claims
- 0795US7253187B2Heterocyclic inhibitors of ERK2 and uses thereofVERTEX PHARMA·Filed 2004·Granted Aug 7, 2007·90 cites·25 claims
- 0895US6699865B2Pyrazole compositions useful as inhibitors of ERKVERTEX PHARMA·Filed 2003·Granted Mar 2, 2004·71 cites·21 claims
- 0995US6593357B1Pyrazole compositions useful as inhibitors of ERKVERTEX PHARMA·Filed 2002·Granted Jul 15, 2003·81 cites·21 claims
- 1093US10786512B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Sep 29, 2020·3 cites·8 claims
- 1193US7056944B2Pyrazole compositions useful as inhibitors of erkVERTEX PHARMA·Filed 2003·Granted Jun 6, 2006·56 cites·24 claims
- 1292US11440907B1Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Sep 13, 2022·3 cites·25 claims
- 1392US10973830B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Apr 13, 2021·3 cites·23 claims
- 1492US7964624B1Inhibitors of serine proteasesVERTEX PHARMA·Filed 2007·Granted Jun 21, 2011·21 cites·27 claims
- 1592US7501415B2Selective inhibitors of ERK protein kinase and uses thereofVERTEX PHARMA·Filed 2005·Granted Mar 10, 2009·25 cites·7 claims
- 1692US7358258B2Prodrugs of an ERK protein kinase inhibitorVERTEX PHARMA·Filed 2005·Granted Apr 15, 2008·23 cites·6 claims
- 1791US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 1890US9987284B2Substituted benzooxadiazole DNA-PK inhibitorsVERTEX PHARMA·Filed 2016·Granted Jun 5, 2018·5 cites·23 claims
- 1989US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 2089US10258627B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·4 cites·19 claims
- 2187USRE49500EPyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates theretoVERTEX PHARMA·Filed 2020·Granted Apr 25, 2023·1 cites·17 claims
- 2287US7985762B2Inhibitors of serine proteasesVERTEX PHARMA·Filed 2006·Granted Jul 26, 2011·8 cites·54 claims
- 2387US7407962B2Heteroaryl compounds useful as inhibitors or protein kinasesVERTEX PHARMA·Filed 2004·Granted Aug 5, 2008·29 cites·16 claims
- 2486US12251387B2Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitorsVERTEX PHARMA·Filed 2023·Granted Mar 18, 2025·0 cites·20 claims
- 2585US6875789B2Pyrazole-derived kinase inhibitors and uses thereofVERTEX PHARMA·Filed 2002·Granted Apr 5, 2005·24 cites·5 claims
- 2684US6750239B2Pyrazole-derived kinase inhibitors and uses thereofVERTEX PHARMA·Filed 2002·Granted Jun 15, 2004·22 cites·27 claims
- 2784US2025188070A1Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 2882US2023183276A1Pyrrole inhibitors of erk protein kinase, synthesis thereof and intermediates theretoVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2979US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 3079US10815225B2Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Oct 27, 2020·1 cites·50 claims
- 3179US7462612B2Pyridine inhibitors of ERK2 and uses thereofVERTEX PHARMA·Filed 2005·Granted Dec 9, 2008·4 cites·15 claims
- 3278USRE48266EPyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates theretoVERTEX PHARMA·Filed 2019·Granted Oct 20, 2020·1 cites·17 claims
- 3378US8440706B2Inhibitors of serine proteasesCOTTRELL KEVIN M·Filed 2011·Granted May 14, 2013·3 cites·12 claims
- 3477US12473285B2DCN-1 modulating compounds and methods of use thereofCELLARITY INC·Filed 2024·Granted Nov 18, 2025·0 cites·30 claims
- 3577US12195453B2Antiproliferation compounds and uses thereofMERCK PATENT GMBH·Filed 2022·Granted Jan 14, 2025·0 cites·24 claims
- 3677US7183307B2Pyrazole-derived kinase inhibitors and uses thereofVERTEX PHARMACEUTICALS INCROPO·Filed 2004·Granted Feb 27, 2007·15 cites·7 claims
- 3777US2021236505A1Substituted quinoxaline dna-pk inhibitorsVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3876US11813267B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2020·Granted Nov 14, 2023·0 cites·19 claims
- 3975USRE47318EPyrrole inhibitors of erk protein kinase, synthesis thereof and intermediates theretoVERTEX PHARMA·Filed 2016·Granted Mar 26, 2019·1 cites·17 claims
- 4073USRE46097EPyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates theretoVERTEX PHARMA·Filed 2013·Granted Aug 9, 2016·1 cites·13 claims
- 4171US12435087B2Modulators of DCN-1 and methods of use thereofCELLARITY INC·Filed 2024·Granted Oct 7, 2025·0 cites·27 claims
- 4269US8372873B2Inhibitors of serine proteasesVERTEX PHARMA·Filed 2011·Granted Feb 12, 2013·1 cites·23 claims
- 4369US2018311254A1Dna-pk inhibitorsVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 4468US2023265080A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 4564US2016354381A1Dna-pk inhibitorsObligated Assignee·Filed 2016·Application pending·0 cites
- 4661US2025257063A1Dcn-1 modulating compounds and methods of use thereofCELLARITY INC·Filed 2025·Application pending·0 cites
- 4754US12502376B2Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)VERTEX PHARMA·Filed 2021·Granted Dec 23, 2025·0 cites·33 claims
- 4853US2023159502A1Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 4953US2023339915A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 5053US2023159504A17- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Qing Tang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →